Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001628280-18-000456
Filing Date
2018-01-18
Accepted
2018-01-18 17:16:55
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-1/A menlos-1a2.htm S-1/A 3545824
2 EXHIBIT 10.1 s-1a2exhibit101.htm EX-10.1 217046
3 EXHIBIT 10.2 s-1a2exhibit102.htm EX-10.2 593729
4 EXHIBIT 23.1 s-1a2exhibit231.htm EX-23.1 3640
5 chronicitchcough.jpg GRAPHIC 703289
6 cumulativedistributionfuncti.jpg GRAPHIC 37192
7 image001a05.jpg GRAPHIC 169709
8 menlologo.jpg GRAPHIC 125687
9 tcp101vaschangefrombaselinen.jpg GRAPHIC 110258
10 updatedpipelineimagev2.jpg GRAPHIC 54514
  Complete submission text file 0001628280-18-000456.txt   5995327
Mailing Address 4085 CAMPBELL AVENUE, SUITE 200 MENLO PARK CA 94025
Business Address 4085 CAMPBELL AVENUE, SUITE 200 MENLO PARK CA 94025 650-486-1416
Menlo Therapeutics, Inc. (Filer) CIK: 0001566044 (see all company filings)

EIN.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-222324 | Film No.: 18534726
SIC: 2834 Pharmaceutical Preparations